Search Results

There are 25238 results for: content related to: Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831

  1. You have free access to this content
    Systemic therapy for early-stage HER2-positive breast cancers: Time for a less-is-more approach?

    Cancer

    Volume 121, Issue 4, February 15, 2015, Pages: 517–526, Elisavet Paplomata, Rita Nahta and Ruth M. O'Regan

    Version of Record online : 24 OCT 2014, DOI: 10.1002/cncr.29060

  2. You have full text access to this OnlineOpen article
    Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

    Cancer

    Volume 120, Issue 17, September 1, 2014, Pages: 2657–2664, Peter A. Kaufman, Kenneth J. Bloom, Howard Burris, Julie R. Gralow, Musa Mayer, Mark Pegram, Hope S. Rugo, Sandra M. Swain, Denise A. Yardley, Miu Chau, Deepa Lalla, Bongin Yoo, Melissa G. Brammer and Charles L. Vogel

    Version of Record online : 13 JUN 2014, DOI: 10.1002/cncr.28710

  3. You have free access to this content
    HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma

    Cancer

    Volume 120, Issue 3, 1 February 2014, Pages: 415–424, Harry H. Yoon, William R. Sukov, Qian Shi, Christopher A. Sattler, Anne E. Wiktor, Robert B. Diasio, Tsung-Teh Wu, Robert B. Jenkins and Frank A. Sinicrope

    Version of Record online : 21 OCT 2013, DOI: 10.1002/cncr.28435

  4. You have free access to this content
    Management of patients with HER2-positive metastatic breast cancer: Is there an optimal sequence of HER2-directed approaches?

    Cancer

    Volume 121, Issue 1, January 1, 2015, Pages: 17–24, Amelia B. Zelnak and Kari B. Wisinski

    Version of Record online : 23 JUL 2014, DOI: 10.1002/cncr.28815

  5. You have free access to this content
    Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years

    Cancer

    Volume 120, Issue 10, 15 May 2014, Pages: 1548–1556, Masaaki Kawai, Kathleen E. Malone, Mei-Tzu C. Tang and Christopher I. Li

    Version of Record online : 5 FEB 2014, DOI: 10.1002/cncr.28601

  6. You have free access to this content
    Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status

    Cancer

    Volume 119, Issue 17, 1 September 2013, Pages: 3113–3122, Louis P. Garrison Jr., Deepa Lalla, Melissa Brammer, Joseph B. Babigumira, Bruce Wang and Edith A. Perez

    Version of Record online : 17 JUN 2013, DOI: 10.1002/cncr.28196

  7. You have free access to this content
    Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831

    Cancer

    Volume 119, Issue 13, 01 July 2013, Pages: 2447–2454, Jennifer A. Crozier, Alvaro Moreno-Aspitia, Karla V. Ballman, Amylou C. Dueck, Barbara A. Pockaj and Edith A. Perez

    Version of Record online : 12 APR 2013, DOI: 10.1002/cncr.28051

  8. You have free access to this content
    Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer

    Cancer

    Volume 120, Issue 13, 1 July 2014, Pages: 1932–1938, Rashmi K. Murthy, Ankur Varma, Priyankana Mishra, Kenneth R. Hess, Elliana Young, James L. Murray, Kimberly H. Koenig, Stacy L. Moulder, Amal Melhem-Bertrandt, Sharon H. Giordano, Daniel Booser, Vicente Valero, Gabriel N. Hortobagyi and Francisco J. Esteva

    Version of Record online : 26 MAR 2014, DOI: 10.1002/cncr.28689

  9. You have free access to this content
    Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation

    Cancer

    Volume 119, Issue 16, 15 August 2013, Pages: 3043–3051, Eunice L. Kwak, Geoffrey I. Shapiro, Seth M. Cohen, Carlos R. Becerra, Heinz-Josef Lenz, Wen-Fang Cheng, Wu-Chou Su, Meghan Robohn, Florence Le Maulf, Maximilian T. Lobmeyer, Vikram K. Chand and A. John Iafrate

    Version of Record online : 14 JUN 2013, DOI: 10.1002/cncr.28120

  10. You have free access to this content
    A note from history: Landmarks in history of cancer, part 7

    Cancer

    Volume 121, Issue 15, August 1, 2015, Pages: 2480–2513, Steven I. Hajdu, Manjunath Vadmal and Ping Tang

    Version of Record online : 14 APR 2015, DOI: 10.1002/cncr.29365

  11. You have free access to this content
    Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer

    Cancer

    Volume 119, Issue 22, 15 November 2013, Pages: 3943–3951, Patrick G. Morris, Neil M. Iyengar, Sujata Patil, Carol Chen, Alyson Abbruzzi, Robert Lehman, Richard Steingart, Kevin C. Oeffinger, Nancy Lin, Beverley Moy, Steven E. Come, Eric P. Winer, Larry Norton, Clifford A. Hudis and Chau T. Dang

    Version of Record online : 26 AUG 2013, DOI: 10.1002/cncr.28284

  12. HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium

    Cancer

    Volume 123, Issue 21, November 1, 2017, Pages: 4099–4105, Rathi N. Pillai, Madhusmita Behera, Lynne D. Berry, Mike R. Rossi, Mark G. Kris, Bruce E. Johnson, Paul A. Bunn, Suresh S. Ramalingam and Fadlo R. Khuri

    Version of Record online : 25 JUL 2017, DOI: 10.1002/cncr.30869

  13. You have free access to this content
    Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors

    Cancer

    Volume 119, Issue 11, 1 June 2013, Pages: 1960–1968, David Groheux, Mathieu Hatt, Elif Hindié, Sylvie Giacchetti, Patricia de Cremoux, Jacqueline Lehmann-Che, Antoine Martineau, Michel Marty, Caroline Cuvier, Catherine Cheze-Le Rest, Anne de Roquancourt, Dimitris Visvikis and Marc Espié

    Version of Record online : 15 MAR 2013, DOI: 10.1002/cncr.28020

  14. Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ hybridization for the determination of HER2 gene amplification in breast cancer

    Cancer

    Volume 123, Issue 12, June 15, 2017, Pages: 2230–2239, Alana R. Donaldson, Shashirekha Shetty, Zhen Wang, Christine L. Rivera, Bryce P. Portier, G. Thomas Budd, Erinn Downs-Kelly, Christopher P. Lanigan and Benjamin C. Calhoun

    Version of Record online : 13 FEB 2017, DOI: 10.1002/cncr.30592

  15. Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study

    Cancer

    Volume 123, Issue 7, April 1, 2017, Pages: 1115–1123, Nour Sneige, Kenneth R. Hess, Asha S. Multani, Yun Gong and Nuhad K. Ibrahim

    Version of Record online : 28 NOV 2016, DOI: 10.1002/cncr.30460

  16. You have free access to this content
    Differences in driver genes between smoking-related and non–smoking-related lung cancer in the Chinese population

    Cancer

    Volume 121, Issue S17, September 1, 2015, Pages: 3069–3079, Lan-Ying Gou, Fei-Yu Niu, Yi-Long Wu and Wen-Zhao Zhong

    Version of Record online : 1 SEP 2015, DOI: 10.1002/cncr.29531

  17. You have free access to this content
    Magnetic resonance imaging in patients with newly diagnosed breast cancer: A review of the literature

    Cancer

    Volume 120, Issue 14, 15 July 2014, Pages: 2080–2089, Melissa Pilewskie and Tari A. King

    Version of Record online : 18 APR 2014, DOI: 10.1002/cncr.28700

  18. You have free access to this content
    Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer

    Cancer

    Volume 120, Issue 5, 1 March 2014, Pages: 624–632, Julie E. Bauman and Robert L. Ferris

    Version of Record online : 12 NOV 2013, DOI: 10.1002/cncr.28380

  19. You have free access to this content
    Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study

    Cancer

    Volume 121, Issue 12, June 15, 2015, Pages: 1937–1948, Ines Vaz-Luis, Melissa E. Hughes, Angel M. Cronin, Hope S. Rugo, Stephen B. Edge, Beverly Moy, Richard L. Theriault, Michael J. Hassett, Eric P. Winer and Nancy U. Lin

    Version of Record online : 10 MAR 2015, DOI: 10.1002/cncr.29310

  20. You have free access to this content
    Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma

    Cancer

    Volume 121, Issue 20, October 15, 2015, Pages: 3600–3611, Guoqing Qian, Ning Jiang, Dongsheng Wang, Scott Newman, Sungjin Kim, Zhengjia Chen, Gabriela Garcia, Gavin MacBeath, Dong M. Shin, Fadlo R. Khuri, Zhuo G. Chen and Nabil F. Saba

    Version of Record online : 20 JUL 2015, DOI: 10.1002/cncr.29549